{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:47:39Z","timestamp":1759160859848},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0731-9","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T15:53:18Z","timestamp":1419868398000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Twenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei-Ming","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Zhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Lan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"731_CR1","volume-title":"Global incidence and prevalence of selected curable sexually transmitted infections - 2008","author":"World Health Organization (WHO)","year":"2012","unstructured":"World Health Organization (WHO): Global incidence and prevalence of selected curable sexually transmitted infections - 2008. 2012, WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland"},{"key":"731_CR2","first-page":"11","volume":"266","author":"X Qiu","year":"2013","unstructured":"Qiu X, Jiang N, Gong X: [Reports on syphilis and gonorrhea in China in 2012]. Bulletin Sex Transm Dis. 2013, 266: 11-21.","journal-title":"Bulletin Sex Transm Dis"},{"issue":"Suppl 4","key":"731_CR3","doi-asserted-by":"publisher","first-page":"iv63","DOI":"10.1136\/sextrans-2013-051225","volume":"89","author":"AE Jerse","year":"2013","unstructured":"Jerse AE, Deal CD: Vaccine research for gonococcal infections: where are we?. Sex Transm Infect. 2013, 89 (Suppl 4): iv63-iv68. 10.1136\/sextrans-2013-051225.","journal-title":"Sex Transm Infect"},{"key":"731_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","volume":"13","author":"CA Ison","year":"2013","unstructured":"Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM: GRASP Collaborative group: Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011. Lancet Infect Dis. 2013, 13: 762-768. 10.1016\/S1473-3099(13)70143-9.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"731_CR5","doi-asserted-by":"publisher","first-page":"iv3","DOI":"10.1136\/sextrans-2013-051395","volume":"89","author":"FJ Ndowa","year":"2013","unstructured":"Ndowa FJ, Ison CA, Cole MJ, Lusti-Narasimhan M: Gonococcal antimicrobial resistance: challenges for public health control. Sex Transm Infect. 2013, 89 (Suppl 4): iv3-iv4. 10.1136\/sextrans-2013-051395.","journal-title":"Sex Transm Infect"},{"key":"731_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM: Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014, 27: 587-613. 10.1128\/CMR.00010-14.","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 4","key":"731_CR7","doi-asserted-by":"publisher","first-page":"iv52","DOI":"10.1136\/sextrans-2012-050913","volume":"89","author":"CA Ison","year":"2013","unstructured":"Ison CA, Deal C, Unemo M: Current and future treatment options for gonorrhoea. Sex Transm Infect. 2013, 89 (Suppl 4): iv52-iv56. 10.1136\/sextrans-2012-050913.","journal-title":"Sex Transm Infect"},{"key":"731_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo M, Nicholas RA: Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012, 7: 1401-1422. 10.2217\/fmb.12.117.","journal-title":"Future Microbiol"},{"key":"731_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","volume":"309","author":"VG Allen","year":"2013","unstructured":"Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE: Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA. 2013, 309: 163-170. 10.1001\/jama.2012.176575.","journal-title":"JAMA"},{"key":"731_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QCO.0000000000000025","volume":"27","author":"DA Lewis","year":"2014","unstructured":"Lewis DA: Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis. 2014, 27: 62-67. 10.1097\/QCO.0000000000000025.","journal-title":"Curr Opin Infect Dis"},{"key":"731_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jac\/dkm544","volume":"61","author":"M Liao","year":"2008","unstructured":"Liao M, Bell K, Gu WM, Yang Y, Eng NF, Fu W, Wu L, Zhang CG, Chen Y, Jolly AM, Dillon JA: Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai. J Antimicrob Chemother. 2008, 61: 478-487. 10.1093\/jac\/dkm544.","journal-title":"J Antimicrob Chemother"},{"key":"731_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/jac\/dkl301","volume":"58","author":"Y Yang","year":"2006","unstructured":"Yang Y, Liao M, Gu WM, Bell K, Wu L, Eng NF, Zhang CG, Chen Y, Jolly AM, Dillon JA: Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J Antimicrob Chemother. 2006, 58: 868-872. 10.1093\/jac\/dkl301.","journal-title":"J Antimicrob Chemother"},{"key":"731_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00007435-200204000-00010","volume":"29","author":"S Ye","year":"2002","unstructured":"Ye S, Su X, Wang Q, Yin Y, Dai X, Sun H: Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993\u20131998. Sex Transm Dis. 2002, 29: 242-245. 10.1097\/00007435-200204000-00010.","journal-title":"Sex Transm Dis"},{"key":"731_CR14","volume-title":"[Guidelines for diagnosis and treatment of sexually transmitted diseases 2007]. Center for Control of Sexually Transmitted Diseases, Center for Disease Control, China (China CDC)","author":"Q Wang","year":"2007","unstructured":"Wang Q, Zhang G: [Guidelines for diagnosis and treatment of sexually transmitted diseases 2007]. Center for Control of Sexually Transmitted Diseases, Center for Disease Control, China (China CDC). 2007, Shanghai Sciences and Technology Publishing, Shanghai, China 200235"},{"key":"731_CR15","volume-title":"[Guidelines for the treatment of sexually transmitted infections 2000]","author":"Ministry of Health China","year":"2000","unstructured":"Ministry of Health China: [Guidelines for the treatment of sexually transmitted infections 2000]. 2000, National Center for Leprosy and STD Control, Nanjing, China"},{"key":"731_CR16","unstructured":"National Centre for STD Control, China CDC: [Bulletin of Sexually Transmitted Diseases], [Available at: http:\/\/www.ncstdc.org\/list.asp?id=185 ; 4 May 2014, date last accessed)."},{"key":"731_CR17","volume-title":"Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement M100-S24","author":"Clinical and Laboratory Standard Institute","year":"2014","unstructured":"Clinical and Laboratory Standard Institute: Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement M100-S24. 2014, CLSI Wayne, PA, USA"},{"key":"731_CR18","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST): Expert rules 2010 [Available at: http:\/\/www.eucast.org\/expert_rules . AST to Bacteria Breakpoint Table Version 1.1.; 3 May 2014, date last accessed]."},{"issue":"Suppl 4","key":"731_CR19","doi-asserted-by":"publisher","first-page":"iv5","DOI":"10.1136\/sextrans-2013-051162","volume":"89","author":"RD Kirkcaldy","year":"2013","unstructured":"Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA: Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012. Sex Transm Infect. 2013, 89 (Suppl 4): iv5-iv10. 10.1136\/sextrans-2013-051162.","journal-title":"Sex Transm Infect"},{"key":"731_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1139\/cjm-2013-0357","volume":"59","author":"I Martin","year":"2013","unstructured":"Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Lovgren M, Haldane D, Caeseele PV, Horsman G, Garceau R, Ratnam S, Wong T, Gilmour M: Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010. Can J Microbiol. 2013, 59: 671-678. 10.1139\/cjm-2013-0357.","journal-title":"Can J Microbiol"},{"key":"731_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1473-3099(14)70015-5","volume":"14","author":"MM Lahra","year":"2014","unstructured":"Lahra MM, Donovan B, Whiley DM: Decreased susceptibility to cephalosporins among gonococci?. Lancet Infect Dis. 2014, 14: 186-10.1016\/S1473-3099(14)70015-5.","journal-title":"Lancet Infect Dis"},{"key":"731_CR22","first-page":"E166","volume":"36","author":"MM Lahra","year":"2012","unstructured":"Lahra MM: Australian Gonococcal Surveillance Programme: Annual report of the Australian Gonococcal Surveillance Programme, 2011. Commun Dis Intell. 2012, 36: E166-E173.","journal-title":"Commun Dis Intell"},{"issue":"Suppl 4","key":"731_CR23","doi-asserted-by":"publisher","first-page":"iv36","DOI":"10.1136\/sextrans-2012-050905","volume":"89","author":"JA Dillon","year":"2013","unstructured":"Dillon JA, Trecker MA, Thakur SD: Gonococcal Antimicrobial Surveillance Program Network in Latin America and Caribbean 1990\u20132011: Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities. Sex Transm Infect. 2013, 89 (Suppl 4): iv36-iv41. 10.1136\/sextrans-2012-050905.","journal-title":"Sex Transm Infect"},{"key":"731_CR24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/OLQ.0b013e3180ca8f24","volume":"34","author":"X Su","year":"2007","unstructured":"Su X, Jiang F, Ge Q, Dai X, Sun H, Ye S: Surveillance of antibmicrobial susceptibilitites in Neisseria gonorrhoeae in Nanjing, China, 1999\u20132006. Sex Transm Dis. 2007, 34: 995-999.","journal-title":"Sex Transm Dis"},{"key":"731_CR25","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/jac\/dku245","volume":"69","author":"SC Chen","year":"2014","unstructured":"Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS: Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother. 2014, 69: 2959-2965. 10.1093\/jac\/dku245.","journal-title":"J Antimicrob Chemother"},{"key":"731_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/OLQ.0000000000000157","volume":"41","author":"BY Zhu","year":"2014","unstructured":"Zhu BY, Yu RX, Yin Y, Chen X, Li W, Dai XQ, Liang M, Gan Q, Huang YJ, Wei JP: Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000\u20132012. Sex Transm Dis. 2014, 41: 501-506. 10.1097\/OLQ.0000000000000157.","journal-title":"Sex Transm Dis"},{"key":"731_CR27","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/jac\/dkt543","volume":"69","author":"SD Thakur","year":"2014","unstructured":"Thakur SD, Starnino S, Horsman GB, Levett PN, Dillon JR: Unique combined penA\/mtrR\/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a \u2018susceptible\u2019 Neisseria gonorrhoeae population. J Antimicrob Chemother. 2014, 69: 1510-1516. 10.1093\/jac\/dkt543.","journal-title":"J Antimicrob Chemother"},{"key":"731_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/OLQ.0b013e31822c664f","volume":"38","author":"I Martin","year":"2011","unstructured":"Martin I, Jayaraman G, Wong T, Liu G, Gilmour M: Canadian Public Health Laboratory Network: Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000\u20132009. Sex Transm Dis. 2011, 38: 892-898. 10.1097\/OLQ.0b013e31822c664f.","journal-title":"Sex Transm Dis"},{"key":"731_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/OLQ.0b013e31827bd64c","volume":"40","author":"TS Hottes","year":"2013","unstructured":"Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G: Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011. Sex Transm Dis. 2013, 40: 46-51. 10.1097\/OLQ.0b013e31827bd64c.","journal-title":"Sex Transm Dis"},{"key":"731_CR30","unstructured":"Public Health Agency of Canada: Canadian Guidelines on Sexually Transmitted Infections, 2008 Edition. Public Health Agency of Canada. Ottawa, ON, Canada; 2008."},{"key":"731_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","volume":"22","author":"C Bignell","year":"2011","unstructured":"Bignell C, Fitzgerald M: UK national guideline for the management of gonorrhea in adults, 2011. Int J STD AIDS. 2011, 22: 541-547. 10.1258\/ijsa.2011.011267.","journal-title":"Int J STD AIDS"},{"key":"731_CR32","volume-title":"National Management Guidelines for Sexually Transmitted Infections 7th edition","author":"Sexual Health Society of Victoria","year":"2008","unstructured":"Sexual Health Society of Victoria: National Management Guidelines for Sexually Transmitted Infections 7th edition. 2008, Sexual Health Society of Victoria, Melbourne, Australia"},{"key":"731_CR33","first-page":"590","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention: Update to CDC\u2019s Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. Morb Mortal Wkly Rep. 2012, 61: 590-594.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR12","key":"731_CR34","first-page":"50","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention: Sexually transmited disease treatment guidelines, 2010. Morb Mortal Wkly Rep. 2010, 59 (RR12): 50-52.","journal-title":"Morb Mortal Wkly Rep"},{"key":"731_CR35","unstructured":"World Health Organization: Antimicrobial resistance in Neisseria gonorrhoeae. Available at WHO\/CDS\/CSR\/DRS\/2001.3. 2001. (3 May 2014, date last accessed). http:\/\/www.who.int\/drugresistance\/Antimicrobial_resistance_in_Neisseria_gonorrhoeae.pdf ,"},{"key":"731_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/jac\/dks449","volume":"68","author":"R Pereira","year":"2013","unstructured":"Pereira R, Cole MJ, Ison CA: Combination therapy for gonorrhoea: in vitro synergy testing. J Antimicrob Chemother. 2013, 68: 640-643. 10.1093\/jac\/dks449.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 4","key":"731_CR37","doi-asserted-by":"publisher","first-page":"iv57","DOI":"10.1136\/sextrans-2012-050910","volume":"89","author":"M Lusti-Narasimhan","year":"2013","unstructured":"Lusti-Narasimhan M, Pessoa-Silva CL, Temmerman M: Moving forward in tackling antimicrobial resistance: WHO actions. Sex Transm Infect. 2013, 89 (Suppl 4): iv57-iv59. 10.1136\/sextrans-2012-050910.","journal-title":"Sex Transm Infect"},{"key":"731_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/sextrans-2012-050674","volume":"88","author":"F Ndowa","year":"2012","unstructured":"Ndowa F, Lusti-Narasimhan M, Unemo M: The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect. 2012, 88: 317-318. 10.1136\/sextrans-2012-050674.","journal-title":"Sex Transm Infect"},{"key":"731_CR39","doi-asserted-by":"crossref","unstructured":"Gil-Setas A, Navascu\u00e9s-Ortega A, Beristain X: Spectinomycin in the treatment of gonorrhoea. Euro Surveill, 2010; 15:pii\u2009=\u200919568. Available at http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19568 . (3 May 2014, date last accessed).","DOI":"10.2807\/ese.15.19.19568-en"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0731-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0731-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:08:53Z","timestamp":1650899333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0731-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"19 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"731"}}